“…Because GABA cannot itself cross the blood brain barrier (BBB), one proposed way to raise therapeutically useful levels of its concentration would be to interfere with this enzyme. Suicide enzyme substrates have often been used for this purpose, and we have been very interested in the tritiation of these agents 137, 138. Regarding GABA, one of the most potent and selective of GABA transaminase inhibitors was found to be 4‐amino‐5‐hexenoic acid ( 33 ), initially discovered by Merrell International chemists in France 139, 140.…”